Vascular Disease Prevention

Vascular disease prevention is important to reduce the incidence of cardiovascular events and the high morbidity and mortality. Here is the latest research.

July 3, 2020

Artificial Intelligence and Hypertension: Recent Advances and Future Outlook

American Journal of Hypertension
Thanat ChaikijurajaiW H Wilson Tang
May 31, 2020

Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis

Mahesh Anantha-NarayananRick A Nishimura
June 3, 2020

Pharmacists of the future: What determines graduates' desire to engage in patient-centred services?

Research in Social & Administrative Pharmacy : RSAP
Dhanya NairCarlo A Marra
June 12, 2020
Comment / Editorial
Open Access

Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care

Kidney Diseases
Philip Kam-Tao LiKamyar Kalantar-Zadeh
June 4, 2020
Open Access

Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?

Polish Archives of Internal Medicine
Ilenia CalcaterraMatteo Nicola Dario Di Minno
June 15, 2020

The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews

Trends in Cardiovascular Medicine
Bárbara S RodriguesDaniel Caldeira
July 3, 2020
Comment / Editorial
Open Access

Lessons from the Implementation of Pilot Practices to Tackle the Burden of Noncommunicable Diseases in Europe

International Journal of Environmental Research and Public Health
Antonio Sarría-SantameraTeresa Corral
July 6, 2020

Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk

Heart Rhythm : the Official Journal of the Heart Rhythm Society
Joost A OfferhausCarol Ann Remme
June 18, 2020

Prevention of Pulmonary and Venous Thromboembolism Post Coronary Artery Bypass Graft Surgery - Literature Review

Brazilian Journal of Cardiovascular Surgery
Mansour Jannati, Alireza Abdi Ardecani
June 26, 2020

Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial

European Heart Journal Cardiovascular Imaging
Carlijn M van der AalstHarry J de Koning
June 26, 2020
Open Access

Targeting mitochondrial fitness as a strategy for healthy vascular aging

Clinical Science
Matthew J RossmanDouglas R Seals
July 11, 2020

Ethnic and Racial Disparities in Acute Myocardial Infarction

Current Cardiology Reports
Steven Simon, P Michael Ho
May 30, 2020

Left Atrial Volume after Heart Transplantation - A Predictor of Outcomes?

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Y PeledB Tzur
June 1, 2020

Coronary and peripheral artery plaques: do differences in plaque characteristics translate to differences in lipid management?

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Shirling Tsai, Gloria Lena Vega

Sign up to follow this feed and discover related papers.

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

© 2020 Meta ULC. All rights reserved